AFL · AFLAC INC

381 filings

AFL SEC Filings

AFLAC INC - 381 total filings

Filing record · 2016–202610-K1110-Q328-K114

Showing 1–50 of 381 filings

AFLAC INC Quarterly Report for Q2 Ended Jun 30, 2026

Aflac Incorporated reported solid financial results for the second quarter and first half of 2026. Net earnings significantly increased year-over-year, driven by improved investment performance and the absence of substantial prior-year investment losses. Aflac Japan, the company's largest segment, experienced a decrease in premiums and adjusted net investment income, partly due to a weaker yen, but saw a reduction in benefits and claims, leading to improved pretax adjusted earnings in yen terms. Aflac U.S. demonstrated growth in net earned premiums and maintained stable adjusted net investment income, though pretax adjusted earnings saw a slight decline due to increased benefits and claims. The company continued its share repurchase program, returning capital to shareholders, and maintained a strong capital position. Management remains focused on managing currency fluctuations and operational risks, including cybersecurity incidents in both Japan and the U.S., which are currently not expected to have a material impact on the company's financial condition.

Aug 7, 2026 8-K

AFLAC INC 8-K Report, Financial Results (Aug 6, 2026)

Aflac reported second-quarter 2026 results that were mixed beneath a headline earnings rebound. GAAP net earnings rose 37.7% to $825 million ($1.63 per diluted share) from $599 million, but this was driven largely by a smaller net investment loss ($153 million vs. $421 million a year ago), not by stronger operations. Adjusted earnings, the company's core measure, fell 7.7% to $883 million, and adjusted EPS declined 1.7% to $1.75. Excluding a 9.3% weaker yen, which cost roughly $0.05 per share, adjusted EPS would have risen 1.1% to $1.80. Total revenues fell 1.0% to $4.1 billion, and net earned premiums dropped 6.3% as yen weakness and a reinsurance transaction at Aflac Japan offset growth in the U.S. Aflac Japan's pretax adjusted earnings rose 3.4% in yen terms, helped by a 250 basis point improvement in the benefit ratio to 64.0% and a pretax margin of 34.3%, but dollar-reported pretax earnings fell 6.2%. Aflac U.S. was weaker, with pretax adjusted earnings down 4.6% and its margin contracting 160 basis points to 20.9% on higher benefit claims. Management pointed to a $26 million expense release and $46 million of reserve remeasurement gains as supporting Q2, while flagging that variable investment income ran $72 million below long-term expectations. The U.S. net earned premium growth outlook for 2026 was trimmed to just below the 3% to 6% guidance range. Capital deployment remained robust. Aflac returned $1.3 billion to shareholders in the quarter, including $983 million of buybacks and $309 million of dividends, and declared a $0.61 quarterly dividend. Adjusted ROE excluding foreign currency remeasurement held at 16.6%, adjusted leverage was 21.8%, and the Japan regulatory ESR was 226% (240% including USP). Investors should weigh the strong capital return and ROE against the year-over-year decline in core adjusted earnings, the currency drag, and the softening top-line trend.

Aug 6, 2026 8-K

AFLAC INC 8-K Report, Corporate Update (Jun 30, 2026)

Aflac Incorporated disclosed in an 8-K filing that its wholly owned subsidiary, Aflac Life Insurance Japan Ltd. ("Aflac Japan"), experienced a cybersecurity incident. An unauthorized third party accessed certain Aflac Japan systems between June 15 and June 25, 2026. While the investigation is ongoing, the compromised data includes policy details, personal information, and bank account information. Aflac Japan has taken steps to contain the breach and continues to serve its policyholders, though some systems were temporarily suspended. The incident is confined to Japan, and Aflac's U.S. operations were not affected. The full impact remains unknown, but potential risks include legal, reputational, and financial consequences, as well as regulatory inquiries and litigation.

Jun 30, 2026 8-K

AFLAC INC 8-K Report, Corporate Update (May 28, 2026)

Aflac Incorporated has announced the successful completion of a significant public offering of senior notes denominated in Japanese Yen (¥). The offering comprises four tranches with varying maturities and interest rates: ¥3.1 billion in 2.117% Senior Notes due 2029, ¥41.8 billion in 2.802% Senior Notes due 2031, ¥13.1 billion in 3.123% Senior Notes due 2033, and ¥7.9 billion in 3.482% Senior Notes due 2036. The aggregate principal amount of the offering is substantial, totaling ¥65.9 billion. The proceeds from this debt issuance are earmarked for general corporate purposes, indicating a strategic move to bolster the company's financial flexibility and support ongoing operations or future initiatives. The offering was conducted under Aflac's existing shelf registration statement and involved a syndicate of underwriters led by prominent financial institutions. The notes are unsecured, ranking equally with existing and future unsecured senior indebtedness, and are governed by an indenture with standard provisions for default and redemption, including par call options on most tranches.

May 28, 2026 8-K

AFLAC INC 8-K Report, Corporate Update (May 14, 2026)

Aflac Incorporated announced on May 14, 2026, the successful issuance of $500,000,000 in aggregate principal amount of 5.150% Senior Notes due 2036. This offering was made under the company's existing shelf registration statement and a prospectus supplement dated May 11, 2026. The proceeds from this debt issuance are designated for general corporate purposes. These Senior Notes are unsecured obligations, ranking equally with other existing and future unsecured senior indebtedness of Aflac. The notes bear a fixed interest rate of 5.150% per annum, with semi-annual payments due on May 14 and November 14, commencing November 14, 2026. The company retains the option to redeem the notes under specific conditions, including a "Par Call Date" three months prior to maturity, where redemption will be at par plus accrued interest.

May 14, 2026 8-K

AFLAC INC 8-K Report, Shareholder Vote Results (May 7, 2026)

Aflac Incorporated (AFL) held its Annual Meeting of Shareholders on May 4, 2026, with the results detailed in this 8-K filing. Key outcomes include the approval of all incumbent directors for re-election, the non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the company's independent auditor for fiscal year 2026. These outcomes suggest shareholder confidence in the current board and financial oversight. Notably, a shareholder proposal advocating for an independent board chairman was not approved by the shareholders. The filing also provides details on the total voting power and the voting restrictions associated with the J&A Alliance Trust, which holds a significant stake (20%) and is subject to specific voting agreements, particularly concerning change of control transactions and votes exceeding 20% of total voting rights.

May 7, 2026 10-Q

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2026

Aflac Incorporated reported a strong first quarter for 2026, with net earnings reaching $1.0 billion, a significant increase from $29 million in the prior year's first quarter. This substantial growth was primarily driven by a rebound in investment performance, with net investment gains of $49 million compared to net investment losses of $963 million in Q1 2025. The company's total revenues also saw a notable increase to $4.3 billion, up from $3.4 billion year-over-year, largely due to these improved investment results. Operationally, adjusted earnings were $901 million, slightly down from $906 million in the prior year, reflecting the impact of a weaker yen on Aflac Japan's results. The company continued its capital return program, repurchasing $1.0 billion in common stock during the quarter. Shareholders' equity grew to $30.0 billion, and the company maintained a strong capital position, demonstrating resilience and effective management across its core insurance businesses in Japan and the U.S.

May 6, 2026 8-K

AFLAC INC 8-K Report, Financial Results (Apr 29, 2026)

Aflac (AFL) reported first quarter 2026 results on April 29, 2026, with a headline GAAP swing driven largely by investment gains rather than underlying operations. Total revenues rose 27.9% to $4.3 billion and net earnings were $1.0 billion ($1.98 per diluted share), versus $29 million a year earlier. That comparison is distorted by a $963 million net investment loss in Q1 2025; this quarter included $49 million of net investment gains, driven by derivative and FX gains partly offset by CECL and impairments. The more relevant measure for investors is adjusted earnings, which were $901 million, down 0.6% year over year, while adjusted EPS rose 5.4% to $1.75 on a lower share count. Excluding current-period FX, adjusted EPS grew 6.6% to $1.77. The quality of the quarter was mixed. Aflac Japan's pretax adjusted earnings rose 5.1% on a benefit ratio improvement of 290 basis points, though about 70 basis points of that came from reserve remeasurement gains and net earned premiums fell 3.8% in yen terms. U.S. pretax adjusted earnings rose 1.4%, with a 20.4% margin, and the corporate segment swung to breakeven from a $43 million gain. Reserve remeasurement gains of $82 million also helped the quarter. Capital deployment remained substantial: Aflac repurchased $1.0 billion of stock and paid $315 million in dividends. The quarterly dividend was raised 5.2% to $0.61, with the same amount declared for Q2, extending its streak of annual dividend increases. Capital and liquidity metrics were strong, with a regulatory ESR of 227% (243% including USP), a combined U.S. RBC ratio of about 560%, adjusted leverage of 21.2% (within the 20% to 25% target), and $3.4 billion of unencumbered holding-company liquidity. Adjusted ROE was 12.8%, or 16.4% excluding foreign currency remeasurement.

Apr 29, 2026 10-K

AFLAC INC Annual Report, Year Ended Dec 31, 2025

Aflac Incorporated's 2025 10-K filing reveals a challenging year for the company, marked by a decline in total revenues and net earnings, primarily due to net investment losses. Total revenues decreased by 9.3% to $17.2 billion, and net earnings fell to $3.6 billion ($6.82 per diluted share) from $5.4 billion ($9.63 per diluted share) in the prior year. This performance was significantly impacted by $572 million in net investment losses in 2025, a reversal from the $1.3 billion in net investment gains recorded in 2024. Despite the headwinds, adjusted earnings remained relatively stable at $4.0 billion ($7.49 per diluted share) compared to $4.1 billion ($7.21 per diluted share) in 2024, indicating resilient core operational performance. The company continued its capital return strategy, repurchasing $3.5 billion of its common stock. Shareholders' equity saw an increase to $29.5 billion, supported by favorable changes in discount rate assumptions on insurance reserves, although offset by unrealized losses on investment securities and derivatives. The company also disclosed a cybersecurity incident in June 2025 impacting approximately 22.65 million individuals, though it does not currently anticipate a material financial impact.

Feb 25, 2026 8-K

AFLAC INC 8-K Report, Financial Results (Feb 4, 2026)

Aflac reported fourth-quarter 2025 net earnings of $1.4 billion, or $2.64 per diluted share, down from $1.9 billion ($3.42) a year earlier, but this decline was driven largely by net investment gains of $537 million in Q4 2025 versus $1.0 billion in Q4 2024. Adjusted earnings, the company's preferred measure of insurance operating performance, were $818 million ($1.57 per diluted share), down 5.4% in dollars but up 0.6% per share, as share count reduction offset the earnings decline. For full-year 2025, adjusted earnings per diluted share rose 3.9% to $7.49 (3.5% excluding FX), while GAAP net earnings fell 33% to $3.6 billion ($6.82 per share) because of lower net investment gains. Total revenues declined 9.3% to $17.2 billion for the year. Segment performance was mixed. Aflac Japan's pretax adjusted earnings declined 4.7% in dollars for Q4 and 1.5% for the year, with a strong 31.3% pretax margin, supported by Miraito cancer insurance sales that rose 16.0% for the year. Aflac U.S. net earned premiums grew 4.0% in Q4 and 2.9% for the year, but its Q4 pretax margin fell to 17.4% from 19.7% on higher benefits and expenses. Shareholders' equity rose 13% to $29.5 billion, driven by discount-rate-related AOCI gains, while adjusted book value excluding foreign currency remeasurement was roughly flat per share. Management reiterated a 5.2% increase in the Q1 2026 dividend to $0.61 per share, extending a 43-year streak of dividend increases, and repurchased $800 million of stock in Q4 and $3.5 billion for the year. For 2026, management guided Japan's underlying earned premiums down 1% to 2%, a benefit ratio of 60% to 63%, and a pretax margin of 33% to 36%. For U.S., it guided net earned premium growth at the lower end of 3% to 6%, a benefit ratio of 48% to 52%, an expense ratio of 36% to 39%, and a pretax margin of 17% to 20%. Investors should note that Q4 benefited from roughly $36 million of reserve remeasurement gains and that the U.S. benefit ratio rose 230 basis points year over year.

Feb 4, 2026 10-Q

AFLAC INC Quarterly Report for Q3 Ended Sep 30, 2025

Aflac Incorporated reported a significant turnaround in its third quarter of 2025 compared to the same period in 2024. Total revenues increased to $4.7 billion from $2.9 billion, largely driven by a swing from net investment losses of $1.4 billion in Q3 2024 to net investment gains of $275 million in Q3 2025. This resulted in a net earning of $1.6 billion, or $3.08 per diluted share, a substantial improvement from a net loss of $93 million, or $(0.17) per diluted share, in the prior year's quarter. For the nine months ended September 30, 2025, total revenues were $12.3 billion, down from $13.5 billion in the prior year, primarily due to net investment losses of $1.1 billion in 2025 compared to net investment gains of $239 million in 2024. Consequently, net earnings for the nine-month period decreased to $2.3 billion, or $4.21 per diluted share, from $3.5 billion, or $6.23 per diluted share, in the same period of 2024. The company's adjusted earnings, which exclude certain volatile items, showed more stable performance, with Q3 2025 adjusted earnings at $1.3 billion ($2.49 per diluted share) compared to $1.2 billion ($2.16 per diluted share) in Q3 2024. The company continued its share repurchase program, buying back $2.7 billion of stock in the first nine months of 2025, and maintained a strong shareholder equity position.

Nov 5, 2025 8-K

AFLAC INC 8-K Report, Financial Results (Nov 4, 2025)

Aflac reported third-quarter 2025 net earnings of $1.6 billion, or $3.08 per diluted share, versus a net loss of $93 million a year earlier. The swing is driven mainly by net investment gains of $275 million this quarter compared with net investment losses of $1.4 billion in Q3 2024. The more important figure for investors is adjusted earnings, which rose 9.6% to $1.3 billion, and adjusted EPS, which rose 15.3% to $2.49. Adjusted EPS excludes net investment gains and losses, so it better reflects the underlying insurance business. Adjusted ROE was 19.1%, or 22.1% excluding foreign currency remeasurement. The quarter was helped by a large favorable reserve remeasurement. Management said the assumption update added about $0.76 to EPS, with reserve remeasurement gains of $580 million. Aflac Japan's pretax margin reached 52.2%, versus 44.7% a year earlier, and management attributed much of that to the actuarial unlock rather than to run-rate improvement. Underlying premium trends are softer: Japan's net earned premiums fell 4.0%, and underlying earned premiums fell 1.2%. Aflac U.S. net earned premiums grew 2.5% and its pretax margin was 21.7%, although the U.S. expense ratio rose on a one-time $21 million contract termination fee. Capital deployment remained strong. The company repurchased $1.0 billion of stock, a record for the company, and declared a fourth-quarter dividend of $0.58 per share, extending its 43-year streak of annual dividend increases. Management raised its 2025 Japan benefit ratio range to 58% to 60% and expects a Japan pretax margin of 35% to 38%, while the U.S. guidance is unchanged. Holding company liquidity was $4.5 billion, and leverage was 22.0%, within the 20% to 25% target. Investors should weigh the strong headline earnings against the reliance on favorable reserve and actuarial effects, along with the 2025 cumulative yen effect and the June 2025 network security incident.

Nov 4, 2025 8-K

AFLAC INC 8-K Report, Financial Obligation (Aug 27, 2025)

Aflac Incorporated (AFL) has announced the completion of two significant contingent funding arrangements through the issuance of Pre-Capitalized Trust Securities (P-Caps) by two separate trusts: Wynnton Funding Trust (2035 Trust) and Wynnton Funding Trust II (2055 Trust). These transactions, totaling $2 billion ($1 billion each), provide Aflac with the flexibility to issue up to $1 billion each of its 5.251% Senior Notes due 2035 and 5.991% Senior Notes due 2055, respectively, to these trusts over a ten-year and thirty-year period. The P-Caps are designed to serve as a contingent funding mechanism, with the trusts investing proceeds in U.S. Treasury securities. These arrangements are structured as private placements and are primarily for qualified institutional buyers. The company will pay annual facility fees on the unexercised portion of the funding commitment. The P-Caps and underlying senior notes have provisions for automatic or required exercise under certain default or financial deterioration scenarios for Aflac, as well as options for early redemption by the company. This strategic move enhances Aflac's financial flexibility and contingency planning by securing access to long-term capital at predetermined rates.

Aug 27, 2025 8-K

AFLAC INC 8-K Report, Financial Results (Aug 5, 2025)

Aflac reported second-quarter 2025 U.S. GAAP net earnings of $599 million, or $1.11 per diluted share, down sharply from $1.8 billion ($3.10) a year earlier. The decline is driven by net investment losses of $421 million this quarter versus gains of $696 million in the prior-year period, mainly from $452 million of losses on certain derivatives and foreign currency activities. Excluding these items, the core metric is adjusted earnings, which fell 7.5% to $957 million, and adjusted EPS, which fell 2.7% to $1.78. Adjusted EPS excluding current-period FX was $1.73, down 5.5%, so the stronger yen contributed a $0.04 tailwind. Underlying operations were mixed. Aflac Japan's pretax adjusted earnings fell 8.6% in dollar terms and 15.0% in yen terms, with the pretax margin declining to 32.0% from 35.3%. Japan's yen net earned premiums fell 4.8%, but new annualized premium sales rose 23.2% to ¥20.7 billion, led by the Miraito cancer product. Aflac U.S. grew more steadily, with net earned premiums up 3.4%, sales up 2.7%, pretax adjusted earnings up 1.3%, and persistency at 79.2%. Adjusted ROE was 13.7% (16.4% excluding foreign currency remeasurement), and adjusted book value per share excluding foreign currency remeasurement rose 5.2% to $44.17. Capital deployment remained strong: Aflac repurchased $829 million of stock in the quarter, leaving 30.9 million shares authorized, and declared a $0.58 third-quarter dividend. Holding-company liquidity rose to $5.1 billion after a ¥150 billion debt issuance, and adjusted leverage rose to 22.5%, still within the 20–25% target. The filing also notes a June 2025 unauthorized network access incident, which is a risk factor investors should monitor.

Aug 5, 2025 10-Q

AFLAC INC Quarterly Report for Q2 Ended Jun 30, 2025

Aflac Incorporated reported its financial results for the second quarter and first six months of 2025. Total revenues declined to $4.2 billion for the quarter and $7.6 billion for the six months, primarily due to a significant drop in net investment gains from $696 million in Q2 2024 to a loss of $421 million in Q2 2025, and from $1.6 billion in the first six months of 2024 to a loss of $1.4 billion in the same period of 2025. Consequently, net earnings saw a substantial decrease, with quarterly net earnings falling to $599 million ($1.11 per diluted share) from $1.8 billion ($3.10 per diluted share) in the prior year's quarter, and six-month net earnings dropping to $628 million ($1.16 per diluted share) from $3.6 billion ($6.35 per diluted share). Despite the decline in reported earnings, the company's "adjusted earnings," which exclude investment gains/losses and other non-recurring items, remained relatively stable. Adjusted earnings for the quarter were $957 million ($1.78 per diluted share), down slightly from $1.0 billion ($1.83 per diluted share) in Q2 2024. For the first six months, adjusted earnings were $1.8 billion ($3.43 per diluted share), compared to $2.0 billion ($3.49 per diluted share) in the prior year's period. The company repurchased $1.7 billion of its common stock in the first six months of 2025, indicating continued capital return to shareholders. Shareholders' equity increased to $27.2 billion, reflecting significant positive impacts from changes in discount rate assumptions on insurance reserves, partially offset by investment market volatility and foreign currency translation losses.

Aug 5, 2025 8-K

AFLAC INC 8-K Report, Corporate Update (Jun 20, 2025)

Aflac Incorporated has disclosed a cybersecurity incident where unauthorized access to its network was identified on June 12, 2025. The company's incident response protocols were promptly activated, and the intrusion was contained within hours without impacting business operations, ransomware, or the ability to service policyholders. While the company's core functions remain operational, a review of potentially impacted files is underway. These files may contain sensitive personal information, including claims, health, and social security numbers, belonging to customers, beneficiaries, employees, and agents within its U.S. operations. The full scope and potential financial or reputational impact of the incident are currently unknown and under investigation. Aflac anticipates notifying affected individuals and relevant regulators, and will offer free credit monitoring and identity theft protection services. The company has engaged external cybersecurity experts to assist in its response and the ongoing review.

Jun 20, 2025 8-K

AFLAC INC 8-K Report, Corporate Update (Jun 5, 2025)

On June 5, 2025, Aflac Incorporated issued ¥74.9 billion of yen-denominated senior notes in a registered public offering across four maturities (2030, 2032, 2035, and 2040), with coupons from 1.726% to 2.779%. The offering was made under a May 30, 2025 underwriting agreement, with Mizuho, Morgan Stanley MUFG, and SMBC Nikko as representatives. The notes are senior unsecured obligations that rank equally with the company's other unsecured senior debt. Proceeds are earmarked for general corporate purposes, and the filing does not break down a specific use. The 8-K also discloses a separate private placement, entered into May 29, 2025, of ¥75.1 billion of yen-denominated senior notes maturing in 2032, 2035, 2040, and 2045, with coupons from 1.990% to 3.040%. Both issuances are yen-denominated, which lets Aflac raise capital in Japan's lower-rate market, a core part of its funding strategy given its large Japanese operations. Together the two issuances total roughly ¥150 billion, or on the order of $1 billion at recent exchange rates. The filing is a routine debt-financing disclosure with no new financial results, guidance, or changes to ratings or capital returns. For investors, the key takeaways are the size and cost of the new debt, which extends the company's maturity profile out to 2045, and the continued reliance on low-cost yen funding. The filing does not report leverage ratios, interest expense impact, or how the proceeds will be deployed, so those details would need to come from Aflac's periodic reports or earnings materials.

Jun 5, 2025 8-K

AFLAC INC 8-K Report, Shareholder Vote Results (May 8, 2025)

Aflac Incorporated (AFL) filed an 8-K report on May 7, 2025, detailing the outcomes of its Annual Meeting of Shareholders held on May 5, 2025. The key takeaway for investors is the overwhelming shareholder approval of all proposals presented, including the election of all 11 director nominees, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year 2025. This strong endorsement suggests continued confidence in the company's leadership and governance. Furthermore, the report clarifies the voting structure and the influence of the J&A Alliance Trust, which holds 20% of the total voting power. The existing Shareholders Agreement mandates the Trust to vote proportionally with other shareholders on certain matters, ensuring that the Trust's significant stake does not unilaterally dictate outcomes on those specific issues. The high turnout and broad support across all proposals indicate a stable shareholder base and a consensus on the company's direction.

May 8, 2025 10-Q

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2025

Aflac Incorporated (AFL) reported a significant year-over-year decline in net earnings for the first quarter of 2025, primarily driven by a substantial shift from net investment gains in the prior year to net investment losses in the current quarter. Net earnings were $29 million, or $0.05 per diluted share, compared to $1.9 billion, or $3.25 per diluted share, in the first quarter of 2024. This swing is largely attributable to mark-to-market movements in investments and derivatives, particularly a significant net investment loss of $963 million in Q1 2025 versus a net investment gain of $951 million in Q1 2024. Despite the sharp decline in reported net earnings, adjusted earnings, which exclude certain volatile investment and foreign currency impacts, were $906 million, or $1.66 per diluted share, a slight decrease from $961 million, or $1.66 per diluted share, in the prior year. The company's operations in Japan, Aflac Japan, continue to be the larger segment, though yen weakening impacted dollar-denominated results. Aflac U.S. showed modest growth in net earned premiums and maintained stable profitability. The company continued its share repurchase program, returning $900 million to shareholders in the quarter. Shareholders' equity saw an increase, largely due to positive impacts from changes in discount rate assumptions on insurance reserves, although offset by unrealized losses on investments and foreign currency translation. Investors should focus on the adjusted earnings and operational performance metrics, as the reported net earnings are heavily influenced by market volatility. The company's core insurance business, particularly in Japan, remains robust, demonstrating resilience despite challenging investment market conditions. The continued share buybacks signal management's confidence in the company's underlying financial health.

May 7, 2025 8-K

AFLAC INC 8-K Report, Financial Results (Apr 30, 2025)

Aflac reported a sharply weaker first quarter 2025 on a U.S. GAAP basis, with net earnings of just $29 million ($0.05 per diluted share) versus $1.9 billion ($3.25) a year earlier. The drop was driven almost entirely by a $963 million net investment loss, mostly from $888 million of losses on certain derivatives and foreign currency activities, rather than by operating deterioration. Total revenues fell 37.5% to $3.4 billion for the same reason. Investors should therefore focus on the non-GAAP adjusted measures, which strip out investment gains and losses. On an adjusted basis, the quarter was steady. Adjusted earnings were $906 million ($1.66 per diluted share), down 5.7% in dollars but flat per share, as a share count reduction of about 5% offset the decline. Aflac Japan's pretax adjusted earnings fell 10.9% in dollars (8.7% in yen) to $722 million, pressured by lower net earned premiums and floating-rate investment income, though the benefit ratio improved. Aflac U.S. was resilient, with pretax adjusted earnings up 0.6% to $358 million, net earned premiums up 1.8%, and persistency at 79.3%. Management also flagged that the weaker yen reduced adjusted EPS by $0.01 and that variable investment income ran $27 million below long-term expectations. Capital deployment remained active. Aflac repurchased $900 million of stock (8.5 million shares) and declared a $0.58 quarterly dividend, continuing its streak of annual increases. Book value per share rose to $48.55 on a GAAP basis, and adjusted book value excluding foreign currency remeasurement grew 2.2% to $42.61. Adjusted ROE was 12.7% (15.6% excluding FX remeasurement). Overall, the filing shows a headline GAAP loss from non-operating items, while the core insurance franchise held up reasonably well.

Apr 30, 2025 10-K

AFLAC INC Annual Report, Year Ended Dec 31, 2024

Aflac Incorporated (AFL) reported solid financial results for the fiscal year ending December 31, 2024. Total revenues reached $18.9 billion, a slight increase from the previous year, while net earnings grew significantly to $5.4 billion, or $9.63 per diluted share, up from $4.7 billion ($7.78 per diluted share) in 2023. This growth was driven by a strong increase in net investment gains, which more than doubled to $1.3 billion. The company also continued its share repurchase program, buying back $2.8 billion of its common stock, and announced a 16.0% increase in its quarterly cash dividend, signaling confidence in its financial health and commitment to returning capital to shareholders. The company's performance was notably impacted by foreign currency fluctuations, with the Japanese yen weakening by 6.9% against the U.S. dollar on average during 2024. While this impacted adjusted earnings per diluted share negatively by $0.18, the company's core operations in both Aflac Japan and Aflac U.S. remain robust. Aflac Japan continues to be the principal contributor to earnings, with a strong focus on its third sector insurance products, while Aflac U.S. shows growth in its product lines and continues to invest in digital enhancements.

Feb 26, 2025 8-K

AFLAC INC 8-K Report, Financial Results (Feb 5, 2025)

Aflac reported solid fourth-quarter and full-year 2024 results on February 5, 2025. Q4 adjusted earnings rose 18.2% to $865 million ($1.56 per diluted share, up 24.8%), and full-year adjusted EPS grew 15.7% to $7.21 (18.6% excluding the weaker yen). GAAP net earnings were inflated by $1.0 billion of Q4 net investment gains, mainly from derivatives and FX, so GAAP EPS of $3.42 overstates underlying performance. Investors should focus on adjusted figures. Adjusted book value excluding FX remeasurement rose 3.2% to $42.46 per share, and the adjusted ROE excluding FX remeasurement was 14.5% for the quarter. Aflac Japan was the main driver, with pretax adjusted earnings up 1.0% in Q4 and a full-year pretax margin of 36.0%, the highest in about 30 years, though yen-denominated premiums fell 6.9% for the year. U.S. pretax adjusted earnings were up 9.3% in Q4 but down 5.5% for the full year, with sales declining 1.0% and the company citing a shift toward more profitable growth. Management reiterated a 16% increase in the first-quarter dividend to $0.58 per share, marking 42 consecutive years of dividend increases, and deployed $750 million in Q4 buybacks ($2.8 billion for the year). For 2025, management guided Japan's benefit ratio toward the high end of 64% to 66%, its expense ratio to the low end of 20% to 23%, and its pretax margin to the low end of 30% to 33%. For the U.S., it guided the benefit ratio to the low end of 48% to 52%, the expense ratio to the high end of 36% to 39%, and the pretax margin to the high end of 17% to 20%. These updates signal lower Japan profitability in 2025 than 2024's exceptional margin, which is an important consideration for investors.

Feb 5, 2025 10-Q

AFLAC INC Quarterly Report for Q3 Ended Sep 30, 2024

Aflac Incorporated (AFL) reported a net loss of $93 million, or $(0.17) per diluted share, for the third quarter of 2024, a significant decrease from a net earning of $1.57 billion, or $2.64 per diluted share, in the same period last year. This decline was primarily driven by substantial foreign exchange-related losses due to the strengthening Japanese yen and significant net investment losses totaling $1.4 billion, compared to net investment gains of $423 million in the prior year's third quarter. For the nine-month period ended September 30, 2024, net earnings were $3.54 billion, or $6.23 per diluted share, down from $4.39 billion, or $7.28 per diluted share, in the same period last year. The year-to-date investment results also showed a decline, with net investment gains of $239 million compared to $1.1 billion in the prior year. Despite the reported net loss in the quarter, adjusted earnings showed a more favorable trend, increasing year-over-year due to strong performance in the Japan segment and expense control measures in the U.S. segment. The company continued its share repurchase program, repurchasing $2.1 billion of common stock during the first nine months.

Nov 1, 2024 8-K

AFLAC INC 8-K Report, Financial Results (Oct 30, 2024)

Aflac reported a third-quarter 2024 GAAP net loss of $93 million, or $0.17 per diluted share, versus earnings of $1.6 billion, or $2.64 per share, a year earlier. The swing was driven by $1.4 billion of net investment losses, mainly from derivatives and foreign currency activity as the yen strengthened about 12.9% during the quarter. Total revenues fell 40.4% to $2.9 billion. Investors should focus on the underlying results. Adjusted earnings rose 10.6% to $1.2 billion, and adjusted EPS grew 17.4% to $2.16 (19.0% to $2.19 excluding the $0.03 currency impact). Aflac Japan was the main driver, with pretax adjusted earnings up 25.5% in yen terms and a pretax margin of 44.7%, helped by roughly ¥39.7 billion of remeasurement gains. The U.S. segment was weaker, with pretax adjusted earnings down 26.8% and a margin of 20.8%, reflecting lower remeasurement gains and higher claims. Balance sheet and capital metrics were mixed but stable. Adjusted book value per share was $51.21, and book value per share including unrealized FX translation losses rose 7.3% to $43.77. The annualized adjusted ROE was 16.7%, or 17.0% excluding currency impact. Aflac repurchased $500 million of stock (4.9 million shares) and declared a $0.50 quarterly dividend, extending its streak of annual dividend increases to 42 years in 2024. Adjusted leverage rose to 21.0% because of yen-driven changes in the value of yen-denominated debt, which management described as an intentional part of its hedging program. The 8-K also disclosed a leadership change. Virgil R. Miller will become President of Aflac effective January 1, 2025, while continuing as President of Aflac U.S. Daniel P. Amos will step down as President but remain Chairman and CEO. Management indicated that the U.S. net earned premium growth will likely be at the low end of its 3% to 5% guidance range, and that Japan's full-year benefit ratio will be 62% to 63%, with a 35% to 36% pretax margin.

Oct 30, 2024 10-Q

AFLAC INC Quarterly Report for Q2 Ended Jun 30, 2024

Aflac Incorporated reported solid financial results for the second quarter and first six months of 2024. Total revenues saw a slight decrease in Q2 2024 to $5.1 billion from $5.2 billion in Q2 2023, but increased year-to-date to $10.6 billion from $10.0 billion in the prior year. Net earnings demonstrated strong growth, reaching $1.8 billion ($3.10 per diluted share) in Q2 2024, up from $1.6 billion ($2.71 per diluted share) in Q2 2023. For the year-to-date period, net earnings rose to $3.6 billion ($6.35 per diluted share) from $2.8 billion ($4.64 per diluted share) in the same period last year. The company's investment portfolio performance was a key driver, with net investment gains increasing in both periods, notably bolstered by derivative and foreign currency activities. Aflac Japan continues to be the primary contributor to earnings, though it experienced a decrease in net earned premiums year-over-year, partly due to internal reinsurance activity and policy features. The company's adjusted earnings, which exclude certain non-operational or volatile items, also showed positive growth, indicating underlying business strength. Shareholder returns remained a focus, with significant share repurchases and an increased dividend declared for the third quarter.

Aug 1, 2024 8-K

AFLAC INC 8-K Report, Financial Results (Jul 31, 2024)

Aflac reported Q2 2024 results on July 31, 2024, with net earnings of $1.8 billion ($3.10 per diluted share), up 14.4% from $2.71 a year earlier, helped by $696 million of net investment gains, largely from derivatives and FX activity. Adjusted earnings, the company's preferred underlying measure, rose 8.5% to $1.0 billion, and adjusted EPS grew 15.8% to $1.83. Excluding a $0.07 currency headwind from the weaker yen, adjusted EPS would have increased 19.6% to $1.89. Total revenues slipped 0.7% to $5.1 billion, reflecting a 6.9% decline in net earned premiums that was largely driven by Japan's prior-year reinsurance transaction and paid-up policies. Segment performance was strong. Aflac Japan's pretax adjusted earnings rose 5.1% in dollar terms (18.6% in yen), with a pretax margin of 35.3%, while Aflac U.S. grew pretax adjusted earnings 3.8% to $383 million with a 22.7% margin. U.S. sales rose 2.0% and Japan's total new sales rose 4.5% in yen, which management described as putting the Japan business back on track for the year. Shareholder returns remained robust: the company repurchased a record $800 million of stock (9.3 million shares), declared a $0.50 quarterly dividend, and reported 41 consecutive years of dividend growth. Adjusted book value per share rose 12.1% to $52.26, and adjusted ROE was 14.3% (14.8% excluding FX impact). The main watch items are the sharp decline in Japan's net earned premiums, which fell 5.7% in yen, the rise in the U.S. expense ratio tied to growth initiatives, and commercial real estate loan stress, with a $1.0 billion watchlist and $14 million of additional CECL reserves. Adjusted leverage of 19.5% sat just below management's 20-25% target corridor. Overall, the quarter reflected solid operating earnings growth, strong capital deployment, and a balanced but FX-sensitive profile.

Jul 31, 2024 8-K

AFLAC INC 8-K Report, Shareholder Vote Results (May 10, 2024)

Aflac Incorporated (AFL) filed an 8-K report detailing the results of its Annual Shareholder Meeting held on May 6, 2024. The primary focus of the filing is the outcome of shareholder votes on key corporate matters. Investors will be interested to know that all three proposals put forth were overwhelmingly approved by shareholders. These included the election of ten members to the board of directors, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the company's independent auditor for the fiscal year ending December 31, 2024. The strong approval across all proposals indicates shareholder confidence in the current leadership and governance structure. The report also provided detailed voting breakdowns, highlighting a significant majority of votes cast in favor of each proposal. Notably, the number of broker non-votes was consistent across most director elections and advisory proposals, suggesting a high level of participation and awareness among shareholders. The filing also referenced a Shareholders Agreement concerning J&A Alliance Trust's voting power, which requires proportional voting alignment under specific circumstances, reinforcing the established governance framework.

May 10, 2024 10-Q

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2024

Aflac Incorporated reported strong financial results for the first quarter of 2024. Net earnings increased significantly to $1.9 billion ($3.25 per diluted share) from $1.2 billion ($1.94 per diluted share) in the prior year quarter, driven by substantial net investment gains of $951 million compared to $123 million in Q1 2023. This increase in investment gains was primarily attributed to favorable derivative and foreign currency activities, as well as gains on equity securities and investment sales. The company continued its capital return program, repurchasing $750 million of its common stock during the quarter and increasing its quarterly dividend by 19.0% to $0.50 per share. Shareholders' equity grew to $23.5 billion, reflecting the strong earnings performance. The company's adjusted earnings, which exclude certain investment-related items, remained robust at $961 million ($1.66 per diluted share), showing the underlying stability of its core insurance operations. Geographically, Aflac Japan remains the primary contributor to earnings, with pretax adjusted earnings of $810 million, a slight increase from the prior year. Aflac U.S. also demonstrated solid performance, with pretax adjusted earnings of $356 million. The company's investment portfolio remains diversified, and while there are ongoing considerations related to the commercial real estate market, particularly for office properties, Aflac maintains a strong capital position and focus on prudent risk management.

May 2, 2024 8-K

AFLAC INC 8-K Report, Financial Results (May 1, 2024)

Aflac reported first-quarter 2024 net earnings of $1.9 billion, or $3.25 per diluted share, up 58.2% from $1.2 billion a year earlier. That headline figure was inflated by $951 million of net investment gains, driven mainly by $703 million of gains on derivatives and foreign currency. The more representative measure, adjusted earnings, rose only 0.8% to $961 million, while adjusted EPS grew 7.1% to $1.66 thanks to a lower share count. Excluding a $0.08 negative yen impact, adjusted EPS rose 12.3% to $1.74. Investors should weigh the adjusted figures more heavily when judging underlying growth. Underlying operations were mixed. Aflac Japan's pretax adjusted earnings rose 2.8% in dollar terms to $810 million, with a pretax margin of 32.8% versus 28.2% a year ago, helped by lower benefits and expenses. However, Japan net earned premiums fell 16.3% in dollars and new annualized sales declined 5.1%. Aflac U.S. showed modest growth, with net earned premiums up 3.3% and pretax adjusted earnings up 1.1% to $356 million, though U.S. sales fell 5.2%. The weaker yen, which averaged 148.67 per dollar (11.0% weaker), was a headwind throughout. Capital returns remained strong. Aflac repurchased a record $750 million of stock, retired 9.3 million shares, and declared a second-quarter dividend of $0.50 per share, extending a 41-year streak of dividend growth. Shareholders' equity reached $23.5 billion, or $41.27 per share, and adjusted book value per share rose 12.4% to $50.22. Adjusted ROE was 13.7%, and the company disclosed a commercial real estate watchlist of about $1.2 billion, with roughly $600 million in active foreclosure proceedings.

May 1, 2024 8-K

AFLAC INC 8-K Report, Corporate Update (Mar 21, 2024)

On March 19 and March 21, 2024, Aflac Incorporated (AFL) raised a combined ¥75.0 billion in privately placed yen-denominated senior notes and ¥48.6 billion in registered yen-denominated senior notes, totaling roughly ¥123.6 billion (about $800 million-plus at 2024 exchange rates, an approximation not stated in the filing). The filing is a debt-financing disclosure, not an earnings or operating update, so it contains no information on revenue, profitability, or guidance. The company states that proceeds from both offerings are for general corporate purposes. The private placement comprises five tranches maturing between 2034 and 2054, with coupons from 1.600% to 2.400%. The registered offering comprises three tranches maturing in 2029, 2031 and 2034, with coupons from 1.048% to 1.682%. All notes are senior unsecured obligations that rank equally with Aflac's other unsecured senior debt, and both sets are subject to customary covenants and events of default. The registered notes are also redeemable at par plus accrued interest starting three months (2029 and 2031 notes) or six months (2034 notes) before maturity. For investors, the key takeaways are that Aflac is diversifying its funding base into the yen market and extending its debt maturity profile out to 2054, while locking in comparatively low coupons relative to U.S. dollar debt. The new debt increases Aflac's leverage and interest obligations, which investors should weigh against the company's ability to service them, but the filing provides no balance sheet data to quantify the impact.

Mar 21, 2024 10-K

AFLAC INC Annual Report, Year Ended Dec 31, 2023

Aflac Incorporated reported solid financial performance for the fiscal year ending December 31, 2023. Total revenues reached $18.7 billion, with net earnings of $4.7 billion, or $7.78 per diluted share. Adjusted earnings were $3.7 billion, or $6.23 per diluted share, demonstrating the company's ability to manage its core insurance operations effectively. The company returned significant capital to shareholders, repurchasing approximately $2.8 billion of its common stock and increasing its quarterly cash dividend by 19.0% starting in the first quarter of 2024. The company's primary operations in Japan (Aflac Japan) continue to be the main earnings contributor, accounting for 60% of adjusted revenues. While Aflac Japan experienced a slight decrease in net earned premiums due to internal reinsurance transactions and policy maturities, its adjusted net investment income increased, driven by higher yields on U.S. dollar-denominated investments. Aflac U.S. showed growth in net earned premiums across several product lines, including life and disability, and dental and vision, supported by higher interest rates on its investment portfolio. Looking ahead, Aflac is focused on product development and distribution expansion in both markets, alongside technological modernization and operational efficiencies. The company maintains strong capital ratios in both Aflac Japan and Aflac U.S., aiming for a minimum Solvency Margin Ratio (SMR) of 500% for Japan and a combined Risk-Based Capital (RBC) ratio of approximately 400% for the U.S. operations, underscoring a commitment to financial strength and shareholder value.

Feb 22, 2024 8-K

AFLAC INC 8-K Report, Financial Results (Jan 31, 2024)

Aflac reported Q4 2023 net earnings of $268 million ($0.46 per diluted share), down sharply from prior-year results on a per-share basis, but this decline was driven largely by investment losses and a one-time reinsurance novation charge. Adjusted earnings, the company's preferred operating measure, fell 10.4% to $732 million ($1.25 per diluted share, down 4.6%). Net investment losses of $511 million were driven mainly by derivative and FX losses of $580 million tied to yen movements, and a $151 million pretax loss on a reinsurance treaty novation weighed on Corporate and Other. Full-year 2023 adjusted EPS rose 9.9% to $6.23 (13.4% excluding a $0.19 currency drag), and full-year net earnings were $4.7 billion ($7.78 per diluted share). Segment performance was mixed. Aflac Japan's pretax adjusted earnings grew 9.7% in yen terms, with the pretax margin expanding to 30.4% from 26.7%, though net earned premiums fell 8.5% on paid-up policies and reinsurance transactions. Aflac U.S. showed stronger top-line momentum, with net earned premiums up 1.1% and quarterly sales up 2.6%, but its pretax adjusted earnings fell 10.9% as expenses rose and its expense ratio climbed to 43.4%. Management reiterated a 19% increase in the first-quarter 2024 dividend to $0.50 per share, extending 41 consecutive years of dividend increases, and repurchased $700 million of stock in the quarter ($2.8 billion for the full year). For 2024, management guided Aflac Japan toward a 66-68% benefit ratio, a 19-21% expense ratio, and a 29-31% pretax profit ratio, with underlying Japan net earned premiums expected to decline 1.5% to 2.5%. For Aflac U.S., guidance calls for net earned premiums growth of 3% to 5%, a benefit ratio of 45-47%, and a pretax profit ratio of 19-21%. Key watch items include the sustainability of remeasurement gains that flattered recent benefit ratios, the commercial real estate watchlist (about $1.2 billion, with roughly $500 million in active foreclosure), leverage of 19.7% just below the 20-25% corridor, and yen/dollar sensitivity.

Jan 31, 2024 8-K

AFLAC INC 8-K Report, Executive Changes (Dec 8, 2023)

Aflac Incorporated announced a key leadership transition within its finance department. June P. Howard, Senior Vice President and Chief Accounting Officer, will retire effective December 31, 2023. This marks the end of Ms. Howard's tenure, and the company has moved swiftly to appoint a successor. Robin Blackmon has been named the new Senior Vice President and Chief Accounting Officer, effective January 1, 2024. Ms. Blackmon brings extensive experience within Aflac, having most recently served as Vice President and Deputy Chief Accounting Officer. Her appointment reflects a focus on internal talent and continuity in financial leadership, with a compensation package designed to align with her new responsibilities, including a base salary, annual bonus, and performance-based equity award.

Dec 8, 2023 8-K

AFLAC INC 8-K Report, Executive Changes (Nov 17, 2023)

Aflac Incorporated (AFL) has filed an 8-K report detailing a significant leadership transition and an amendment to its bylaws. Effective January 1, 2024, Daniel P. Amos, currently Chairman and CEO, will also assume the role of President. This appointment consolidates top leadership positions under Mr. Amos, who has a long-standing history with the company. Investors should note that his extensive background and compensation details are available in the company's 2023 proxy statement. Additionally, the company's Board of Directors amended and restated its bylaws, notably removing the 'Article IX Emeritus Directors' provision. While the specific implications of this bylaw change require further review of the full document, it suggests a streamlining or modification of past governance structures. Investors focused on corporate governance should consult the newly amended bylaws, filed as an exhibit with this report.

Nov 17, 2023 10-Q

AFLAC INC Quarterly Report for Q3 Ended Sep 30, 2023

Aflac Incorporated reported solid financial performance for the third quarter and the first nine months of 2023. Total revenues increased year-over-year for the quarter, driven by higher net investment income and modest premium growth. Net earnings saw a slight decrease in the third quarter compared to the prior year, primarily due to higher investment gains in the prior year's period and the impact of foreign currency translation. However, for the nine-month period, net earnings and earnings per share showed growth. Aflac Japan continues to be the primary contributor to earnings, though net earned premiums in yen terms decreased due to limited-pay products reaching premium paid-up status and internal reinsurance activity. Aflac U.S. demonstrated strong performance with increased net earned premiums and pretax adjusted earnings, supported by growth initiatives and improved investment income. The company maintained a strong capital position and liquidity. Shareholder equity increased, and the company continued its share repurchase program, returning significant capital to shareholders through dividends and buybacks. The company remains focused on its long-term strategy of providing financial protection and enhancing shareholder value.

Nov 2, 2023 8-K

AFLAC INC 8-K Report, Executive Changes (Nov 1, 2023)

Aflac Incorporated (AFL) has announced a significant leadership transition involving Frederick J. Crawford, its President and Chief Operating Officer. Mr. Crawford is set to retire from his employee role on September 30, 2024. His current role as President and COO will conclude on December 31, 2023, after which he will transition to an Executive Vice President position until his retirement. This transition outlines Mr. Crawford's compensation and benefits through his retirement. Key terms include a continued base salary of $997,500 annually until his retirement, continued vesting of previously granted performance-based restricted stock based on company performance, and full vesting of his Executive Deferred Compensation Plan upon retirement. He will also receive a lump sum payment for COBRA continuation coverage. This announcement provides clarity on leadership succession and executive compensation arrangements.

Nov 1, 2023 8-K

AFLAC INC 8-K Report, Financial Results (Nov 1, 2023)

Aflac's third-quarter 2023 results showed strong underlying earnings momentum, with adjusted earnings per diluted share up 27.8% to $1.84 and adjusted earnings up 20.3% to $1.1 billion. Reported net earnings fell 11.9% to $1.6 billion ($2.64 per diluted share) versus $1.8 billion a year earlier, but that decline largely reflects the prior-year quarter's $695 million deferred tax release and the timing of net investment gains (here $423 million, primarily from derivatives and currency activity). Total revenues rose 5.2% to $4.95 billion, and the adjusted return on equity excluding foreign currency impact was 16.1%. Management attributed much of the earnings strength to lower benefits, including actuarial assumption unlocks that produced roughly $205 million of remeasurement gains, which flatter the quarter and may not recur at the same level. Segment performance was mixed. Aflac U.S. pretax adjusted earnings rose 38.6% to $478 million with a 28.8% pretax margin, helped by reserve remeasurement gains, while absorbing a software write-off and elevated growth-initiative expenses. Aflac Japan pretax adjusted earnings rose 6.4% in dollar terms (11.4% in yen), but yen-denominated net earned premiums fell 2.8%, and the segment's sales growth was driven largely by the new cancer product. The weaker yen reduced adjusted EPS by $0.06 in the quarter and cut nine-month adjusted EPS growth by about 0.17 per share. Capital and shareholder returns remained strong: the company repurchased $700 million of stock, the Board raised the first-quarter 2024 dividend 19% to $0.50 per share, and holding company liquidity stood at $3.3 billion. Commercial real estate exposure (a roughly $1.0 billion watchlist) and the yen-driven swings in book value and leverage are the main areas for investors to monitor.

Nov 1, 2023 10-Q

AFLAC INC Quarterly Report for Q2 Ended Jun 30, 2023

Aflac Incorporated reported solid financial results for the second quarter and the first half of 2023, demonstrating resilience and profitability. Net earnings for the second quarter of 2023 were $1.6 billion, or $2.71 per diluted share, an increase from $1.4 billion, or $2.17 per diluted share, in the same period last year. For the first half of 2023, net earnings reached $2.8 billion, or $4.64 per diluted share, up from $2.4 billion, or $3.77 per diluted share, in the first half of 2022. Key drivers of performance include strong investment income, particularly from its U.S. dollar-denominated investments, and effective expense management. The company's adjusted earnings, which exclude certain volatile items like net investment gains/losses and foreign currency impacts, also showed strength. Aflac Japan continues to be the primary contributor to earnings, despite the weakening yen, while Aflac U.S. shows steady growth in net earned premiums and an improving pretax adjusted profit margin. The company continued its capital return strategy, repurchasing $1.4 billion of its common stock in the first six months of 2023 and maintaining a strong shareholder equity position. Management remains focused on navigating market volatility and regulatory changes while pursuing strategic growth initiatives.

Aug 2, 2023 8-K

AFLAC INC 8-K Report, Financial Results (Aug 1, 2023)

Aflac reported second-quarter 2023 net earnings of $1.6 billion, or $2.71 per diluted share, up 24.9% from $2.17 a year ago, while adjusted earnings rose a more modest 1.0% in dollars to $954 million. Adjusted earnings per diluted share increased 7.5% to $1.58, held back by a $0.04 negative currency impact. The gap between GAAP and adjusted results was driven by $555 million of net investment gains, largely from derivative and foreign currency activity tied to the weaker yen, which the company excludes from its adjusted measures. Investors should therefore focus on the adjusted figures, where underlying growth was modest. Segment performance was mixed. Aflac Japan's pretax adjusted earnings fell 5.8% in dollars to $822 million, and net earned premiums declined 11.6% in dollars, reflecting limited-pay products reaching paid-up status and a Q1 reinsurance transaction. Aflac U.S. was the bright spot, with pretax adjusted earnings up 7.6% to $369 million, net earned premiums up 2.2%, and a pretax margin of 22.2%. Management noted that Q2 U.S. benefit ratios were unusually low, with roughly 210 basis points of benefit from reserve remeasurement gains, so that tailwind may not persist. Japan's pretax margin rose to 30.4% on favorable claims experience, which also included remeasurement gains. Capital deployment remained active. The company repurchased $700 million of stock (10.5 million shares) in the quarter, leaving 95.8 million shares authorized, and declared a $0.42 third-quarter dividend. Adjusted book value per share rose 11.5% to $46.61, and the adjusted ROE was 13.9%, or 14.3% excluding foreign currency. Leverage of 19.4% sits just below management's 20%–25% corridor, a level the CFO attributed mainly to yen weakness rather than debt changes. Management expects the third-quarter annual assumption review under the new LDTI accounting regime to produce further remeasurement gains or losses.

Aug 1, 2023 8-K

AFLAC INC 8-K Report, Executive Changes (Jun 13, 2023)

Aflac Incorporated (AFL) announced on June 9, 2023, through its Compensation Committee, that it is freezing benefit accruals under two key executive retirement plans: the Supplemental Executive Retirement Plan (SERP) and the American Family Corporation Retirement Plan for Senior Officers (SORP). This freeze will be effective as of December 31, 2023. While all retirement benefit accruals will cease, active participants in the SERP may continue to accrue service towards early or delayed early retirement eligibility, based on their final average earnings as of the freeze date. Accruals related to office use and medical benefits under the SORP will also continue. In conjunction with the freeze, impacted executives will become eligible for "Executive Employer Contributions" under the Aflac Incorporated Executive Deferred Compensation Plan. The specific contribution rates will be determined by the Compensation Committee based on post-freeze compensation. This move signals a shift in how the company provides retirement benefits to its senior executives, moving away from defined benefit structures towards a more deferred compensation model for benefits earned after the freeze date.

Jun 13, 2023 8-K

AFLAC INC 8-K Report, Shareholder Vote Results (May 4, 2023)

This 8-K filing from Aflac Incorporated (AFL) details the outcomes of its Annual Meeting of Shareholders held on May 1, 2023. The key takeaway for investors is the strong shareholder support for the company's board of directors, executive compensation practices, and the ratification of its independent auditor. All proposals put forth, including the election of eleven board members, the advisory vote on executive compensation, and the ratification of KPMG LLP as the independent registered public accounting firm, received overwhelming approval. Furthermore, shareholders voted to hold the "say-on-pay" advisory vote annually, indicating a preference for regular shareholder input on executive compensation. The significant majority of votes in favor across all proposals, coupled with a substantial number of broker non-votes in some instances, suggests broad alignment between management and its shareholders on key governance and financial oversight matters.

May 4, 2023 10-Q

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2023

Aflac Incorporated reported solid financial results for the first quarter of 2023, demonstrating resilience amidst varying economic conditions. The company's net earnings increased to $1.19 billion, or $1.94 per diluted share, a notable improvement from $1.05 billion, or $1.60 per diluted share, in the prior year's first quarter. This growth was supported by strong investment income and effective expense management across its core U.S. and Japan segments. Total revenues, however, saw a slight decrease to $4.80 billion from $5.17 billion in the prior year, largely influenced by a weaker yen which impacted the translation of Aflac Japan's results. Despite this, the company's "adjusted earnings," a non-GAAP measure excluding certain investment gains/losses and foreign currency impacts, showed a positive trend, increasing to $1.0 billion from $942 million year-over-year. Aflac continued its commitment to shareholder returns by repurchasing $700 million of its common stock in the quarter, underscoring its confidence in its financial position and future prospects.

May 1, 2023 8-K

AFLAC INC 8-K Report, Financial Results (Apr 27, 2023)

Aflac Incorporated (NYSE: AFL) reported first quarter 2023 results on April 26, 2023, with net earnings of $1.2 billion ($1.94 per diluted share), up 13.5% in dollar terms and 21.3% per share versus the prior year. Adjusted earnings were $953 million ($1.55 per diluted share), up 1.2% in dollars and 7.6% per share. The per-share figure was helped by a lower share count after $700 million of buybacks (10.3 million shares repurchased). Excluding a $0.07 currency headwind from the weaker yen, adjusted EPS would have risen 12.5% to $1.62. Total revenues fell 7.2% to $4.8 billion, largely due to the weaker yen and the impact of the new long-duration insurance accounting standard (LDTI) adopted January 1, 2023. The quarter's profitability was supported by low benefit ratios in both segments, with Japan's pretax margin rising to 28.2% and the U.S. margin to 21.2%. Management noted that remeasurement gains of roughly $53 million under LDTI helped results, and that variable investment income ran $39 million (about $0.05 per share) below long-term expectations. Aflac Japan's pretax adjusted earnings fell 9.4% in dollar terms but rose 3.2% in yen terms. Japan's sales rose 10.8% in yen, driven by the rollout of its new cancer product, and U.S. sales increased 5.3%. Persistency was a watch item in both markets: 93.9% in Japan (down 40 basis points) and 77.9% in the U.S. (down about 80 basis points). Capital and balance-sheet metrics remained solid. Adjusted ROE was 14.2% (14.8% excluding currency impact), shareholders' equity was $19.8 billion ($32.65 per share), and adjusted book value per share was $44.66. Leverage stood at 20.5%, toward the lower end of management's 20%–25% target corridor. The board declared a $0.42 quarterly dividend, payable June 1, 2023, extending a streak of dividend increases that reached 40 consecutive years in 2022. Management described its posture as defensive, citing evolving economic conditions. Total investments and cash fell to $120.5 billion from $132.6 billion a year earlier, mainly because of the weaker yen and higher interest rates.

Apr 27, 2023 8-K

AFLAC INC 8-K Report, Regulation FD Disclosure (Feb 27, 2023)

Aflac's February 27, 2023 8-K furnishes an updated Q4 2022 Financial Analysts Briefing (FAB) Supplement, recast for the January 1, 2023 adoption of LDTI (ASU 2018-12 as amended). The company voluntarily restated 2021 and 2022 comparative data for presentation purposes only, with a January 1, 2021 transition date. Its most consequential accounting change for the P&L is that the change in the deferred profit liability on limited-payment products moves from benefits and claims to net earned premiums; this reclassification has no effect on net earnings. Investors should read the supplement as a reset of the comparative baseline rather than a change in reported profitability. On a full-year basis, 2022 U.S. GAAP net earnings rose 4.4% to $4,418 million ($6.93 per diluted share, up 10.9%), while adjusted earnings fell 7.9% to $3,614 million ($5.67 per diluted share, down 2.2%). Adjusted EPS excluding current-period foreign currency impact was $6.08, up 4.8%, which highlights the yen weakness that depressed reported results. Net earned premiums fell 12.8% to $14,901 million, and the company's total adjusted revenues declined as well. Aflac Japan pretax adjusted earnings fell 12.6% in dollar terms (down 19.7% in Q4) largely because of yen depreciation, though yen-denominated pretax adjusted earnings rose 4.6%. Aflac U.S. pretax adjusted earnings were roughly flat at $1,359 million, with the U.S. combined ratio improving to 79.0%. Balance sheet metrics show a sharp mark-to-market effect: total shareholders' equity rose to $20,140 million from $17,031 million, while AOCI was a large negative driven by fixed-income unrealized losses and the discount-rate effect. Adjusted book value per share ex-AOCI was $43.18 at year-end 2022 (up 10.7%), and adjusted book value including foreign currency translation was $37.39 (up 3.9%). Adjusted ROE was 13.9%, versus 15.8% in 2021, and the adjusted debt-to-capitalization ratio was 23.4%. Note that the supplement is described as unaudited statistical data and that the company's guidance and risk factors are in its separate filings.

Feb 27, 2023 10-K

AFLAC INC Annual Report, Year Ended Dec 31, 2022

Aflac Incorporated's 2022 10-K filing highlights a year of navigating challenging market conditions, including global economic headwinds and a weakening Japanese yen, which impacted revenues and adjusted earnings. Despite these challenges, the company demonstrated resilience, with net earnings of $4.2 billion and diluted earnings per share of $6.59. A significant portion of the company's operations and assets remain concentrated in Japan, which contributed approximately 69% of total revenues. The company continued its commitment to shareholder returns through share repurchases totaling $2.4 billion and an announced dividend increase. Key financial metrics show a decrease in total revenues to $19.5 billion, while net earnings remained strong at $4.2 billion, reflecting an income tax benefit. Shareholders' equity saw a notable decrease due to unrealized losses on investment securities and derivatives, largely influenced by rising interest rates and foreign currency translation losses. Aflac Japan continues to be the primary earnings contributor, though it experienced a decline in net earned premiums in yen terms. Aflac U.S. showed growth in new annualized premium sales, driven by investments in growth initiatives.

Feb 24, 2023 8-K

AFLAC INC 8-K Report, Executive Changes (Feb 10, 2023)

Aflac Incorporated (AFL) has filed a Form 8-K to announce the approval of its 2023 Management Incentive Plan (2023 MIP) by the Compensation Committee of its Board of Directors on February 9, 2023. This plan outlines the framework for awarding bonuses to officers and other employees based on the achievement of specific performance goals. The Compensation Committee retains broad discretion in administering the plan, including selecting participants, granting awards, determining performance periods and goals, and certifying attainment. This action reflects the company's continued focus on aligning executive and employee compensation with company performance.

Feb 10, 2023 8-K

AFLAC INC 8-K Report, Financial Results (Feb 1, 2023)

Aflac's Q4 2022 results were dominated by a sharp foreign-exchange drag: reported net earnings fell 82.2% to $185 million ($0.30 per diluted share) as the weaker yen produced $521 million of net investment losses, mostly from derivatives and currency activity. Underlying performance was steadier. Adjusted earnings declined 5.2% to $806 million, and adjusted EPS rose 0.8% to $1.29. Excluding an $0.11 FX headwind, adjusted EPS would have been $1.40, up 9.4%. Full-year 2022 adjusted EPS was $5.33, down 10.3% (or down 4.5% excluding the $0.34 FX impact), and reported net earnings were $4.2 billion ($6.59 per diluted share), boosted by a $452 million deferred tax release. Segment trends were mixed. Aflac Japan's pretax adjusted earnings fell 20.6% in dollar terms to $704 million, though the pretax margin improved to 25.5%. Japan's new annualized sales rose 11.4% in the quarter on a new cancer product, but full-year sales were flat, and the weak yen cut dollar-reported premiums sharply. Aflac U.S. was the bright spot: pretax adjusted earnings rose 30.3% to $340 million, helped by unusually low benefit ratios and IBNR releases, while U.S. sales grew 17.4% in the quarter and 16.1% for the year. Management flagged that these low benefit ratios are not expected to persist and that U.S. persistency fell to 77.0%. Capital and shareholder returns remained robust. Management reaffirmed a 5.0% increase in the quarterly dividend to $0.42 per share, extending a 40-year streak of annual dividend increases. Aflac repurchased $600 million of stock in Q4 and $2.4 billion for the full year, with $116.6 million shares remaining under authorization. Leverage was 20.8%, toward the low end of its 20%-25% corridor, and holding company liquidity was $3.1 billion. Adjusted book value per share rose 9.7% to $43.51, though reported book value per share fell 28.7% to $36.35 because of AOCI losses tied to the yen and rising rates.

Feb 1, 2023 10-Q

AFLAC INC Quarterly Report for Q3 Ended Sep 30, 2022

Aflac Incorporated reported solid financial results for the nine months ended September 30, 2022. Net earnings were $4.0 billion, a significant increase from $3.3 billion in the same period of the prior year. This improvement was substantially driven by a $695 million income tax benefit recognized in the third quarter due to a change in tax accounting method for foreign currency translation. Excluding this tax benefit, adjusted earnings were $2.6 billion for the first nine months of 2022, a decrease from $3.2 billion in the prior year, reflecting the impact of a weaker Japanese yen and planned investments in the U.S. business. The company's total revenues decreased to $15.5 billion from $16.7 billion year-over-year, primarily due to lower net earned premiums, particularly in Aflac Japan, impacted by economic conditions and the yen's depreciation. Despite revenue pressures, Aflac Japan saw a 10.2% increase in sales in yen terms in the third quarter, driven by new product launches. Aflac U.S. continued its positive sales momentum with an 11.8% increase in the third quarter. Total investments and cash stood at $114.5 billion, down from $143.0 billion at the end of 2021, reflecting strategic portfolio management and share repurchases. Shareholders' equity decreased to $24.2 billion from $33.3 billion, impacted by adverse movements in accumulated other comprehensive income, primarily related to unrealized losses on fixed maturity securities and foreign currency translation losses. The company continues to return capital to shareholders, repurchasing $1.8 billion of common stock and paying dividends, demonstrating confidence in its ongoing financial strength.

Nov 2, 2022 8-K

AFLAC INC 8-K Report, Financial Results (Oct 31, 2022)

Aflac's third quarter 2022 results were headlined by GAAP net earnings of $1.6 billion, or $2.53 per diluted share, but this figure was inflated by a one-time $695 million release of deferred taxes. The more representative measure, adjusted earnings, fell 29.7% year over year to $725 million, and adjusted EPS declined 24.8% to $1.15. Management attributed the drop to a sharp spike in COVID-related claims in Japan (the Japan benefit ratio rose 940 basis points, which the CFO estimated at a $0.29 per share hit), a $0.11 per share shortfall in alternative investment returns, and a weaker yen that reduced EPS by $0.08. A $70 million make-whole call gain partially offset these headwinds. The segment picture was mixed. Aflac Japan's pretax adjusted earnings fell 19.2% in yen terms, and its pretax margin compressed to 21.6% from 26.3%, though management expects the benefit ratio to normalize in the fourth quarter after the scope of 'deemed hospitalization' was narrowed on September 26. Aflac U.S. showed weaker persistency (77.6% on a rolling basis, down 230 basis points), higher expense ratios tied to growth investments, and a 13.7% decline in pretax adjusted earnings, although U.S. sales rose 11.8%. Japan sales increased 10.2% on a new cancer product launch. Capital management remained active. Aflac repurchased $650 million of stock (11.1 million shares) and declared a $0.40 quarterly dividend, marking 40 consecutive years of dividend increases. Leverage fell to 19.5%, slightly below the company's 20-25% target corridor, partly because weaker yen reduced the dollar value of yen-denominated debt. Adjusted book value per share including FX translation rose 2.2% to $37.20, and adjusted ROE was 10.6% (11.4% excluding FX). The company also completed a liability management transaction raising ¥180 billion in yen debt at a weighted average coupon of 89 basis points, which management estimates will reduce run-rate interest expense by about $32 million.

Oct 31, 2022 8-K

AFLAC INC 8-K Report, Executive Changes (Oct 25, 2022)

Aflac Incorporated (AFL) filed an 8-K on October 25, 2022, primarily detailing changes in executive compensation and employment terms. The report announces a retirement and transition plan for Eric M. Kirsch, Executive Vice President, Global Chief Investment Officer, and President of Aflac Global Investments. Mr. Kirsch will retire from employment on March 31, 2023, but will continue in his Chief Investment Officer role until December 31, 2022, and then transition to an Executive Vice President role until his retirement. He will also enter into a one-year consulting agreement post-retirement, receiving a substantial annual fee for transition advisory services. Additionally, the company amended the employment agreements for key executives, including Fred Crawford (President and COO), Max Broden (CFO), and Audrey Boone Tillman (General Counsel). These amendments modify the definition of "Good Reason" for termination, notably limiting the grounds upon which an executive can claim "Good Reason" outside of a change in control scenario. Specifically, the removal of "diminution of duties," "assignment of significantly inconsistent duties," and "material breach by the Company" from the "Good Reason" definition suggests a strengthening of the company's position in executive employment contracts.

Oct 25, 2022